Article
Genes, stem cells and biological pacemakers
6 Jul 2004
Abstract excerpt
The advent of gene therapy and cell therapy has led to reconsideration of standard therapies for cardiac disease. One such area of reconsideration is that of the cardiac pacemaker, which has been the mainstay of treatment for high-degree heart block and sinoatrial node dysfunction. Over the past five years, gene therapy has been used to explore the overexpression of beta(2)-adrenergic receptors, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
